Artemin Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-68857
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-NSTWRTVDRLS corresponding to internal region according to NP_476501.1, NP_476431.2.
Epitope
C-NSTWRTVDRLS
Specificity
This antibody is expected to recognize all reported isoforms (NP_003967.2; NP_476501.1; NP_476431.2). Reported variants represent identical protein: NP_476431.2, NP_001129687.1 Reported variants represent identical protein: NP_003967.2, NP_476432.2
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for Artemin Antibody
Western Blot: Artemin Antibody [NBP1-68857]
Western Blot: Artemin Antibody [NBP1-68857] - (0.1ug/ml) staining of HEK293 lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for Artemin Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:8000
Western Blot
0.1 - 0.3 ug/ml
Application Notes
WB: Approx. 28 kDa band observed in lysates of HEK293, HepG2 and Kelly (PMID: 20118197).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: Artemin
Alternate Names
ARTN, Enovin, EVN, Neublastin
Gene Symbol
ARTN
Additional Artemin Products
Product Documents for Artemin Antibody
Product Specific Notices for Artemin Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...